{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T11:31:00Z","timestamp":1785670260428,"version":"3.56.0"},"reference-count":170,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Therapeutic Targets"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1517\/14728222.12.11.1347","type":"journal-article","created":{"date-parts":[[2008,10,14]],"date-time":"2008-10-14T13:21:55Z","timestamp":1223990515000},"page":"1347-1366","source":"Crossref","is-referenced-by-count":70,"title":["The cannabinoid CB\n            <sub>1<\/sub>\n            receptor and the endocannabinoid anandamide: possible antidepressant targets"],"prefix":"10.1517","volume":"12","author":[{"given":"Francis Rodriguez","family":"Bambico","sequence":"first","affiliation":[{"name":"McGill University, Neurobiological Psychiatry Unit, Department of Psychiatry, Research and Training Building, 1033 Pine Avenue West, Montr\u00e9al Qu\u00e9bec, H3A 1A1, Canada ; ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gobbi","sequence":"additional","affiliation":[{"name":"McGill University, Neurobiological Psychiatry Unit, Department of Psychiatry, Research and Training Building, 1033 Pine Avenue West, Montr\u00e9al Qu\u00e9bec, H3A 1A1, Canada ; ;"},{"name":"Universit\u00e9 de Montr\u00e9al, Centre de Recherche Fernand Seguin, Department of Psychiatry, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2008,10,14]]},"reference":[{"key":"e_1_3_1_2_2_1","unstructured":"Burton R. The anatomy of melancholy what it is with all the kinds causes symptoms prognostics and several cures of it. London: J Cuthell; 1862"},{"key":"e_1_3_1_2_3_1","unstructured":"Moreau (de Tours) JJ. Du hachisch et de l'alienation mentale in Du hachisch et de l'alienation mental. Moreau Paris JJ editor. Paris: Librairie de Fortin Masson et Cie; 1845"},{"key":"e_1_3_1_2_4_1","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-TR). 4th edition. Washington DC: American Psychiatric Association; 2000"},{"key":"e_1_3_1_2_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.6.617"},{"key":"e_1_3_1_2_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1846"},{"key":"e_1_3_1_2_7_1","first-page":"1253","volume":"167","author":"Remick","year":"2002","unstructured":"Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ 2002;167:1253-60","journal-title":"CMAJ"},{"key":"e_1_3_1_2_8_1","first-page":"4","volume":"62","author":"Lecrubier","year":"2001","unstructured":"Lecrubier Y. The burden of depression and anxiety in general medicine. J Clin Psychiatry 2001;62(Suppl):4-9","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_2_9_1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1177\/070674372001460101001","volume":"46","author":"Parikh","year":"2001","unstructured":"Parikh SV, Lam RW; CANMAT Depression Work Group. Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence and health burden. Can J Psychiatry 2001;46(Suppl 1):S13-20","journal-title":"Can J Psychiatry"},{"key":"e_1_3_1_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(94)90315-8"},{"key":"e_1_3_1_2_11_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.1.28"},{"key":"e_1_3_1_2_12_1","first-page":"239","volume":"1","author":"Shopsin","year":"1975","unstructured":"Shopsin B, Gershon S, Goldstein M, et al. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Commun 1975;1(2):239-49","journal-title":"Psychopharmacol Commun"},{"key":"e_1_3_1_2_13_1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/BF00965591","volume":"11","author":"Reader","year":"1986","unstructured":"Reader TA, Bri\u00e8re R, Grondin L, Ferron A. Effects of p-chlorophenylalanine on cortical monoamines and on the activity of noradrenergic neurons. Neurochem Res 1986;11(7):1025-35","journal-title":"Neurochem Res"},{"key":"e_1_3_1_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(80)90461-6"},{"key":"e_1_3_1_2_15_1","first-page":"174","volume":"29","author":"Lesch","year":"2004","unstructured":"Lesch KP. Gene\u2013environment interaction and the genetics of depression. J Psychiatry Neurosci 2004;29:174-84","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_3_1_2_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.6.556"},{"key":"e_1_3_1_2_17_1","doi-asserted-by":"crossref","unstructured":"Delgado PL Miller HL Salomon RM et al. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. 1999;46(2):212-20","DOI":"10.1016\/S0006-3223(99)00014-1"},{"key":"e_1_3_1_2_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.8.729"},{"key":"e_1_3_1_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00223-7"},{"key":"e_1_3_1_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2005.03.032"},{"key":"e_1_3_1_2_21_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.CRJ04005X"},{"key":"e_1_3_1_2_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0953-816x.2001.01583.x"},{"key":"e_1_3_1_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.02.012"},{"key":"e_1_3_1_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(03)00123-4"},{"key":"e_1_3_1_2_25_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-23-10150.1998"},{"key":"e_1_3_1_2_26_1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1097\/00001756-200112210-00011","volume":"12","author":"Aznar","year":"2001","unstructured":"Aznar S, Knudsen GM. Serotonin induces a decrease of 5-HT(1A) immunoreactivity in organotypic hippocampal cultures. Neuroreport 2001;12(18):3909-12","journal-title":"Neuroreport"},{"key":"e_1_3_1_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)02135-3"},{"key":"e_1_3_1_2_28_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1300.016"},{"key":"e_1_3_1_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)00069-9"},{"key":"e_1_3_1_2_30_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002"},{"key":"e_1_3_1_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2003.08.003"},{"key":"e_1_3_1_2_32_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000"},{"key":"e_1_3_1_2_33_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.157.1.115"},{"key":"e_1_3_1_2_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083328"},{"key":"e_1_3_1_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.04.011"},{"key":"e_1_3_1_2_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1629"},{"key":"e_1_3_1_2_37_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1144400"},{"key":"e_1_3_1_2_38_1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0091-3057(91)90347-5","volume":"40","author":"Mechoulam","year":"1991","unstructured":"Mechoulam R, Devane WA, Breuer A, et al. A random walk through a cannabis field. Pharmacol Biochem Behav 1991;40(3):461-4","journal-title":"Pharmacol Biochem Behav"},{"key":"e_1_3_1_2_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1063545"},{"key":"e_1_3_1_2_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.122149199"},{"key":"e_1_3_1_2_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn879"},{"key":"e_1_3_1_2_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1137406"},{"key":"e_1_3_1_2_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1247"},{"key":"e_1_3_1_2_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg143"},{"key":"e_1_3_1_2_45_1","author":"Atha","year":"1997","unstructured":"Atha MJ, Blanchard S. Regular users \u2013 self-reported drug consumption patterns and attitudes to drugs among 1333 regular cannabis users. Independent Drug Monit Unit 1997","journal-title":"Independent Drug Monit Unit"},{"key":"e_1_3_1_2_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.01750330041007"},{"key":"e_1_3_1_2_47_1","unstructured":"Regelson W Butler JR Schulz J et al. Delta-9-THC as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. In: Bruade MC Szara S editors The pharmacology of marijuana. New York: Raven Press; 1976"},{"key":"e_1_3_1_2_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.0.CO;2-C"},{"key":"e_1_3_1_2_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2004.00271.x"},{"key":"e_1_3_1_2_50_1","first-page":"28","volume":"3","author":"Schnelle","year":"1999","unstructured":"Schnelle M, Grotenhermen F, Reif M, et al. Results of a standardized survey on the medical use of cannabis products in the German-speaking area. Forsch Komplementarmed 1999;3(Suppl):28-36","journal-title":"Forsch Komplementarmed"},{"key":"e_1_3_1_2_51_1","doi-asserted-by":"publisher","DOI":"10.1159\/000112901"},{"key":"e_1_3_1_2_52_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000127707.07621.72"},{"key":"e_1_3_1_2_53_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100002584"},{"key":"e_1_3_1_2_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/104990910402100206"},{"key":"e_1_3_1_2_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200401010-00005"},{"key":"e_1_3_1_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.07.011"},{"key":"e_1_3_1_2_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31811ed205"},{"key":"e_1_3_1_2_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/346561a0"},{"key":"e_1_3_1_2_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.4.322"},{"key":"e_1_3_1_2_60_1","doi-asserted-by":"crossref","unstructured":"Jones RT. Marihuana-induced \u201chigh\u201d: influence of expectation setting and previous drug experience. 1971;23(4):359-69","DOI":"10.1016\/S0031-6997(25)06900-5"},{"key":"e_1_3_1_2_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1169-0"},{"key":"e_1_3_1_2_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1976.tb49882.x"},{"key":"e_1_3_1_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00202-H"},{"key":"e_1_3_1_2_64_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.2033"},{"key":"e_1_3_1_2_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7374.1195"},{"key":"e_1_3_1_2_66_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00103.x"},{"key":"e_1_3_1_2_67_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.2.110"},{"key":"e_1_3_1_2_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61162-3"},{"key":"e_1_3_1_2_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200509000-00006"},{"key":"e_1_3_1_2_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-0179-3-25"},{"key":"e_1_3_1_2_71_1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1375\/twin.10.6.805","volume":"10","author":"Ehlers","year":"2007","unstructured":"Ehlers CL, Slutske WS, Lind PA, et al. Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians. Twin Res Hum Genet 2007;10(6):805-11","journal-title":"Twin Res Hum Genet"},{"key":"e_1_3_1_2_72_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.tpj.6500301","volume":"5","author":"Barrero","year":"2005","unstructured":"Barrero FJ, Ampuero I, Morales B, et al. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics 2005;5(2):135-41","journal-title":"Pharmacogenomics"},{"key":"e_1_3_1_2_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-007-0660-5"},{"key":"e_1_3_1_2_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001376"},{"key":"e_1_3_1_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.11.033"},{"key":"e_1_3_1_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(00)00552-2"},{"key":"e_1_3_1_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2003.11.005"},{"key":"e_1_3_1_2_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00221-006-0503-x"},{"key":"e_1_3_1_2_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199906030-00008"},{"key":"e_1_3_1_2_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300558"},{"key":"e_1_3_1_2_81_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FMJ04003X4"},{"key":"e_1_3_1_2_82_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-993211"},{"key":"e_1_3_1_2_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2005.09.007"},{"key":"e_1_3_1_2_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200312020-00015"},{"key":"e_1_3_1_2_85_1","unstructured":"Hillard CJ Hill MN Carrier EJ et al. Regulation of cannabinoid receptor expression by chronic unpredictable stress in rats and mice. Program No. 746.19\/W22. 2006 Neuroscience Meeting Planner. 2006. Atlanta GA: Society for Neuroscience. Available from: http:\/\/www.abstractsonline.com\/viewer\/viewAbstractPrintFriendly.asp?CKey={E784B249-55A4-4026- [Last accessed 2008 September 7]"},{"key":"e_1_3_1_2_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.12.001"},{"key":"e_1_3_1_2_87_1","unstructured":"Hill MN Ho WV Carrier EJ et al. Differential regulation of the endocannabinoid system following treatment with pharmacologically distinct antidepressants. Program No. 447.4. 2005 Neuroscience Meeting Planner. 2005. San Diego CA: Society for Neuroscience. Available from: http:\/\/sfn.scholarone.com\/itin2005\/main.html?new_page_id=126&abstract_id=3846&p_num=447.4& [Last accessed 2008 September 7]"},{"key":"e_1_3_1_2_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.20386"},{"key":"e_1_3_1_2_89_1","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","volume":"45","author":"Patel","year":"2004","unstructured":"Patel S, Roelke CT, Rademacher DJ, et al. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004;45(12):5431-8","journal-title":"Endocrinology"},{"key":"e_1_3_1_2_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2005.03916.x"},{"key":"e_1_3_1_2_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature00839"},{"key":"e_1_3_1_2_92_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0153-06.2006"},{"key":"e_1_3_1_2_93_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2002.02192.x"},{"key":"e_1_3_1_2_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-001-0946-5"},{"key":"e_1_3_1_2_95_1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1460-9568.2004.03556.x","volume":"20","author":"Degroot","year":"2004","unstructured":"Degroot A, Nomikos GG. Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test. Eur J Neurosci 2004;20(4):1059-64","journal-title":"Eur J Neurosci"},{"key":"e_1_3_1_2_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2004.06.006"},{"key":"e_1_3_1_2_97_1","unstructured":"Niwatananun W Myres MJ Eddwards E. Neuropsychopharmacology and molecular pharmacology of the cannabinoid system in the learned helpless model of depression. In: Pharmaceutical sciences. Baltimore MD: University of Maryland; 2000"},{"key":"e_1_3_1_2_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2004.02.009"},{"key":"e_1_3_1_2_99_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1636-07.2007"},{"key":"e_1_3_1_2_100_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25509"},{"key":"e_1_3_1_2_101_1","first-page":"165","volume":"61","author":"Rutkowska","year":"2004","unstructured":"Rutkowska M, Jachimczuk O. Antidepressant-like properties of ACEA (arachidonyl-2-chloroethylamide), the selective agonist of CB1 receptors. Acta Pol Pharm 2004;61(2):165-7","journal-title":"Acta Pol Pharm"},{"key":"e_1_3_1_2_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.03.003"},{"key":"e_1_3_1_2_103_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509591102"},{"key":"e_1_3_1_2_104_1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2202-8-76","volume":"8","author":"Hayase","year":"2007","unstructured":"Hayase T. Chronologically overlapping occurrences of nicotine-induced anxiety and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs. BMC Neurosci 2007;8:76(1-9)","journal-title":"BMC Neurosci"},{"key":"e_1_3_1_2_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0689-4"},{"key":"e_1_3_1_2_106_1","unstructured":"Bambico FR Cassano T Nguyen NT et al. Emotional behavior and serotonergic neurotransmission in fatty acid amide hydrolase (FAAH) knock-out mice. Program No. 914.18. 2007 Neuroscience Meeting Planner. 2007. San Diego CA: Society for Neuroscience; Available from: http:\/\/www.abstractsonline.com\/viewer\/viewAbstractPrintFriendly.asp?CKey={958CC28E-F4DE-47C8- [Last accessed 2008 September 7]"},{"key":"e_1_3_1_2_107_1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1126\/science.415367","volume":"199","author":"Miczek","year":"1978","unstructured":"Miczek KA. 9-tetrahydrocannabinol: antiaggressive effects in mice, rats and squirrel monkeys. Science 1978;199(4336):1459-61","journal-title":"Science"},{"key":"e_1_3_1_2_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.12.013"},{"key":"e_1_3_1_2_109_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001640"},{"key":"e_1_3_1_2_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.10.032"},{"key":"e_1_3_1_2_111_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200312000-00001"},{"key":"e_1_3_1_2_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705100"},{"key":"e_1_3_1_2_113_1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjp.0701980","volume":"124","author":"Malone","year":"1998","unstructured":"Malone DT, Taylor DA. Modulation of \u03949-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat. Br J Pharmacol 1998;124(7):1419-24","journal-title":"Br J Pharmacol"},{"key":"e_1_3_1_2_114_1","first-page":"281","volume":"15","author":"Carlini","year":"1982","unstructured":"Carlini EA, Lindsey CJ. Effect of serotonergic drugs on the aggressiveness induced by delta 9-tetrahydrocannabinol in rem-sleep-deprived rats. Braz J Med Biol Res 1982;15(4-5):281-3","journal-title":"Braz J Med Biol Res"},{"key":"e_1_3_1_2_115_1","doi-asserted-by":"crossref","unstructured":"Aso E Renoir T Ledent C et al. Lack of CB 1 receptor alters serotonin system: an electrophysiological and in vivo microdialysis study [poster P.2.03]. European College of Neuropsychopharmacology Workshop on Neuropsychopharmacology for Young Scientists in Europe; 2008","DOI":"10.1016\/S0924-977X(08)70044-0"},{"key":"e_1_3_1_2_116_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.05149.x"},{"key":"e_1_3_1_2_117_1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-3565(24)38843-3","volume":"296","author":"Gobbi","year":"2001","unstructured":"Gobbi G, Murphy DL, Lesch K, et al. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp Ther 2001;296(3):987-95","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_2_118_1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00001756-199503000-00024","volume":"6","author":"Maudhuit","year":"1995","unstructured":"Maudhuit C, Hamon M, Adrien J. Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. Neuroreport 1995;6(4):681-4","journal-title":"Neuroreport"},{"key":"e_1_3_1_2_119_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-09-03326.2002"},{"key":"e_1_3_1_2_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.03880.x"},{"key":"e_1_3_1_2_121_1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00213-007-0733-z","volume":"191","author":"Pillolla","year":"2007","unstructured":"Pillolla G, Melis M, Perra S, et al. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo. Psychopharmacology 2007;191(3):843-53","journal-title":"Psychopharmacology"},{"key":"e_1_3_1_2_122_1","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1460-9568.2006.04759.x","volume":"23","author":"Muntoni","year":"2006","unstructured":"Muntoni AL, Pillolla G, Melis M, et al. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur J Neurosci 2006;23:2385-94","journal-title":"Eur J Neurosci"},{"key":"e_1_3_1_2_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.01.002"},{"key":"e_1_3_1_2_124_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.5.1932"},{"key":"e_1_3_1_2_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2005.03.036"},{"key":"e_1_3_1_2_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2006.09.110"},{"key":"e_1_3_1_2_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(97)00018-3"},{"key":"e_1_3_1_2_128_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-004-0921-x"},{"key":"e_1_3_1_2_129_1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/PL00005093","volume":"356","author":"Schlicker","year":"1997","unstructured":"Schlicker E, Timm J, Zentner J, et al. Cannabinoid CB1 receptormediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn Schmiedebergs Arch Pharmacol 1997;356(5):583-9","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"e_1_3_1_2_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300601"},{"key":"e_1_3_1_2_131_1","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e3282ee7b44"},{"key":"e_1_3_1_2_132_1","unstructured":"Hattan PR Bambico FR Duranti A et al. Cannabinoids modify hippocampal serotonergic transmission [abstract C-B3058]. 2nd Annual Canadian Neurscience Meeting; 2008; Montreal Quebec"},{"key":"e_1_3_1_2_133_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-3995fje"},{"key":"e_1_3_1_2_134_1","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1074\/jbc.M700678200","volume":"282","author":"Aguado","year":"2007","unstructured":"Aguado T, Romero E, Monory K, et al. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J Biol Chem 2007;282(33):23892-8","journal-title":"J Biol Chem"},{"key":"e_1_3_1_2_135_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.66.2.204"},{"key":"e_1_3_1_2_136_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206590200"},{"key":"e_1_3_1_2_137_1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1124\/jpet.106.107698","volume":"319","author":"Kim","year":"2006","unstructured":"Kim SH, Won SJ, Mao XO, et al. Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogenesis. J Pharmacol Exp Ther 2006;319(1):150-4","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_2_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61721-8"},{"key":"e_1_3_1_2_139_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.7.761"},{"key":"e_1_3_1_2_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61705-X"},{"key":"e_1_3_1_2_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2007.09.008"},{"key":"e_1_3_1_2_142_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199701200-00023"},{"key":"e_1_3_1_2_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00578-0"},{"key":"e_1_3_1_2_144_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fbp.0000135704.56422.40"},{"key":"e_1_3_1_2_145_1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0893-133X(00)00228-1","volume":"24","author":"Mann","year":"2001","unstructured":"Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 2001;24(5):467-77","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_2_146_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.10.2838"},{"key":"e_1_3_1_2_147_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-6-199803150-00009"},{"key":"e_1_3_1_2_148_1","author":"Papakostas","year":"2008","unstructured":"Papakostas GI, Homberger CH, Fava M. A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. J Psychopharmacol 2008; published on 2008 February 28, doi:10.1177\/0269881107083808","journal-title":"J Psychopharmacol"},{"key":"e_1_3_1_2_149_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169036.40755.16"},{"key":"e_1_3_1_2_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.04.005"},{"key":"e_1_3_1_2_151_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301224"},{"key":"e_1_3_1_2_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(03)00145-3"},{"key":"e_1_3_1_2_153_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707682"},{"key":"e_1_3_1_2_154_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050045"},{"key":"e_1_3_1_2_155_1","volume":"51","author":"Blier","year":"1990","unstructured":"Blier P, de Montigny C, Chaput Y. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry 1990;51(Suppl 14-20)","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_2_156_1","first-page":"219","volume":"5","author":"Chaput","year":"1991","unstructured":"Chaput Y, de Montigny C, Blier P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology 1991;5(4):219-29","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_1_2_157_1","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0028-3908(00)00017-4","volume":"39","author":"B\u00e9\u00efque","year":"2000","unstructured":"B\u00e9\u00efque J, de Montigny C, Blier P, Debonnel G. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat. Neuropharmacology 2000;39(10):1800-12","journal-title":"Neuropharmacology"},{"key":"e_1_3_1_2_158_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.1994.43"},{"key":"e_1_3_1_2_159_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000665"},{"key":"e_1_3_1_2_160_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.1912"},{"key":"e_1_3_1_2_161_1","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0924-977X(06)80039-8","volume":"1","author":"Guiard","year":"2006","unstructured":"Guiard BP, Gardier AM, Blier P. Potentiating antidepressant strategy: focus on NK1 receptor antagonists. Eur Neuropsychopharmacol 2006;1(16 Suppl):S31-2","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_3_1_2_162_1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.euroneuro.2006.07.004","volume":"17","author":"Gobbi","year":"2007","unstructured":"Gobbi G, Cassano T, Radja F, et al. Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. Eur Neuropsychopharmacol 2007;17(5):328-38","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_3_1_2_163_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0014-2999(92)90394-J","volume":"211","author":"Blier","year":"1992","unstructured":"Blier P, Bouchard C. Effect of repeated electroconvulsive shocks on serotonergic neurons. Eur J Pharmacol 1992;211(3):365-73","journal-title":"Eur J Pharmacol"},{"key":"e_1_3_1_2_164_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.104166"},{"key":"e_1_3_1_2_165_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145700001772"},{"key":"e_1_3_1_2_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00936-7"},{"key":"e_1_3_1_2_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00284-6"},{"key":"e_1_3_1_2_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01162-3"},{"key":"e_1_3_1_2_169_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2003.02911.x"},{"key":"e_1_3_1_2_170_1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2006.07.080","volume":"1113","author":"Kochman","year":"2006","unstructured":"Kochman LJ, dos Santos AA, Fornal CA, Jacobs BL. Despite strong behavioral disruption, \u03949-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus. Brain Res 2006;1113(1):86-93","journal-title":"Brain Res"},{"key":"e_1_3_1_2_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.10.043"}],"container-title":["Expert Opinion on Therapeutic Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14728222.12.11.1347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T09:47:47Z","timestamp":1756720067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14728222.12.11.1347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,14]]},"references-count":170,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1517\/14728222.12.11.1347"],"URL":"https:\/\/doi.org\/10.1517\/14728222.12.11.1347","relation":{},"ISSN":["1472-8222","1744-7631"],"issn-type":[{"value":"1472-8222","type":"print"},{"value":"1744-7631","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,14]]}}}